Suppr超能文献

表观盐皮质激素过多综合征:病例报告。

Apparent Mineralocorticoid Excess Syndrome: Case Report.

作者信息

Alsaadoun Saad Aqeel, Alrasheedi Ameinah Thamer, Gazar Seham Hossny, Alsallum Ghadah Abdulrahman

机构信息

Division of Nephrology, Department of Pediatrics, King Saud Hospital, Unayzah, Saudi Arabia.

Department of Pediatrics, College of Medicine, Qassim University, Buraydah, Saudi Arabia.

出版信息

Int Med Case Rep J. 2025 Jun 3;18:671-676. doi: 10.2147/IMCRJ.S520238. eCollection 2025.

Abstract

Apparent Mineralocorticoid Excess (AME) syndrome is a rare form of high-blood pressure syndrome caused by genetic mutations in the 11b-hydroxysteroid dehydrogenase type 2 (HSD11B2) gene, inherited in an autosomal recessive manner. The condition can be either congenital or acquired. This report presents two cases of AME in children from consanguineous families identified through clinical assessment and whole-exome sequencing (WES). Symptoms included high blood pressure, hypokalemia, and metabolic alkalosis. AME syndrome was confirmed by WES, which revealed a homozygous missense pathogenic mutation c.622C>T p.(Arg208Cys) in exon 3 of the HSD11B2 gene. Treatment with spironolactone, and potassium chloride alone was not effective, so low-dose dexamethasone was added. Post-treatment, both patients showed significant improvement in their blood pressure and electrolyte levels. Diagnosis of AME syndrome can is often challenging because it is an extremely rare autosomal recessive disorder. Only five cases have been reported in Saudi Arabia, and only four case studies discussed treatment plans. This case report provides additional data to support the current literature and treatment protocols.

摘要

表观盐皮质激素过多(AME)综合征是一种罕见的高血压综合征,由11β-羟类固醇脱氢酶2(HSD11B2)基因的基因突变引起,呈常染色体隐性遗传。该病可为先天性或后天性。本报告介绍了通过临床评估和全外显子组测序(WES)确定的来自近亲家庭的两例儿童AME病例。症状包括高血压、低钾血症和代谢性碱中毒。WES证实了AME综合征,该检测揭示了HSD11B2基因第3外显子中的纯合错义致病突变c.622C>T p.(Arg208Cys)。单独使用螺内酯和氯化钾治疗无效,因此添加了低剂量地塞米松。治疗后,两名患者的血压和电解质水平均有显著改善。AME综合征的诊断通常具有挑战性,因为它是一种极其罕见的常染色体隐性疾病。沙特阿拉伯仅报告了5例,仅有4项病例研究讨论了治疗方案。本病例报告提供了更多数据,以支持当前的文献和治疗方案。

相似文献

1
Apparent Mineralocorticoid Excess Syndrome: Case Report.
Int Med Case Rep J. 2025 Jun 3;18:671-676. doi: 10.2147/IMCRJ.S520238. eCollection 2025.
2
Apparent mineralocorticoid excess syndrome: report of one family with three affected children.
J Pediatr Endocrinol Metab. 2012;25(11-12):1083-8. doi: 10.1515/jpem-2012-0113.
4
Case report: Clinical characteristics and Genetical analysis of in three Chinese children with apparent mineralocorticoid excess: a case series.
Front Endocrinol (Lausanne). 2025 Jan 27;15:1491825. doi: 10.3389/fendo.2024.1491825. eCollection 2024.
5
Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase type 2 deficiency.
Proc Natl Acad Sci U S A. 2017 Dec 26;114(52):E11248-E11256. doi: 10.1073/pnas.1716621115. Epub 2017 Dec 11.
6
Apparent mineralocorticoid excess in Israel: a case series and literature review.
Eur J Endocrinol. 2024 May 2;190(5):347-353. doi: 10.1093/ejendo/lvae049.
7
A Rare Case of Apparent Mineralocorticoid Excess Presenting as Endocrine Hypertension.
Indian J Nephrol. 2025 May-Jun;35(3):427-428. doi: 10.25259/IJN_83_2024. Epub 2024 May 18.
8
Apparent mineralocorticoid excess syndrome in a Brazilian boy caused by the homozygous missense mutation p.R186C in the HSD11B2 gene.
Arq Bras Endocrinol Metabol. 2008 Nov;52(8):1277-81. doi: 10.1590/s0004-27302008000800012.
9
Apparent Mineralocorticoid Excess by a Novel Mutation and Epigenetic Modulation by HSD11B2 Promoter Methylation.
J Clin Endocrinol Metab. 2015 Sep;100(9):E1234-41. doi: 10.1210/jc.2015-1760. Epub 2015 Jun 30.
10
Late-onset apparent mineralocorticoid excess caused by novel compound heterozygous mutations in the HSD11B2 gene.
Hypertension. 2003 Aug;42(2):123-9. doi: 10.1161/01.HYP.0000083340.57063.35. Epub 2003 Jul 14.

本文引用的文献

1
Case report: Clinical characteristics and Genetical analysis of in three Chinese children with apparent mineralocorticoid excess: a case series.
Front Endocrinol (Lausanne). 2025 Jan 27;15:1491825. doi: 10.3389/fendo.2024.1491825. eCollection 2024.
2
Consanguineous Marriage and Its Association With Genetic Disorders in Saudi Arabia: A Review.
Cureus. 2024 Feb 9;16(2):e53888. doi: 10.7759/cureus.53888. eCollection 2024 Feb.
3
Apparent mineralocorticoid excess: comprehensive overview of molecular genetics.
J Transl Med. 2022 Nov 3;20(1):500. doi: 10.1186/s12967-022-03698-9.
4
Antifungal therapy with azoles and the syndrome of acquired mineralocorticoid excess.
Mol Cell Endocrinol. 2021 Mar 15;524:111168. doi: 10.1016/j.mce.2021.111168. Epub 2021 Jan 21.
6
Drug-induced endocrine blood pressure elevation.
Pharmacol Res. 2020 Apr;154:104311. doi: 10.1016/j.phrs.2019.104311. Epub 2019 Jun 15.
7
Apparent mineralocorticoid excess and the long term treatment of genetic hypertension.
J Steroid Biochem Mol Biol. 2017 Jan;165(Pt A):145-150. doi: 10.1016/j.jsbmb.2016.02.014. Epub 2016 Feb 15.
9
Apparent mineralocorticoid excess syndrome: report of one family with three affected children.
J Pediatr Endocrinol Metab. 2012;25(11-12):1083-8. doi: 10.1515/jpem-2012-0113.
10
Tissue-specific modulation of mineralocorticoid receptor function by 11β-hydroxysteroid dehydrogenases: an overview.
Mol Cell Endocrinol. 2012 Mar 24;350(2):168-86. doi: 10.1016/j.mce.2011.07.020. Epub 2011 Jul 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验